- Home
- PTGX vs HUN Comparison
PTGX vs HUN Comparison
Compare PTGX & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- HUN
- Stock Information
- Founded
- PTGX 2006
- HUN 1970
- Country
- PTGX United States
- HUN United States
- Employees
- PTGX N/A
- HUN N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- HUN Major Chemicals
- Sector
- PTGX Health Care
- HUN Industrials
- Exchange
- PTGX Nasdaq
- HUN Nasdaq
- Market Cap
- PTGX 2.8B
- HUN 2.4B
- IPO Year
- PTGX 2016
- HUN 2005
- Fundamental
- Price
- PTGX $42.97
- HUN $12.05
- Analyst Decision
- PTGX Strong Buy
- HUN Hold
- Analyst Count
- PTGX 8
- HUN 9
- Target Price
- PTGX $66.50
- HUN $15.00
- AVG Volume (30 Days)
- PTGX 990.2K
- HUN 4.2M
- Earning Date
- PTGX 05-06-2025
- HUN 05-01-2025
- Dividend Yield
- PTGX N/A
- HUN 8.29%
- EPS Growth
- PTGX N/A
- HUN N/A
- EPS
- PTGX 0.86
- HUN N/A
- Revenue
- PTGX $207,801,000.00
- HUN $5,976,000,000.00
- Revenue This Year
- PTGX N/A
- HUN $4.09
- Revenue Next Year
- PTGX $7.13
- HUN $4.65
- P/E Ratio
- PTGX $50.68
- HUN N/A
- Revenue Growth
- PTGX N/A
- HUN 0.02
- 52 Week Low
- PTGX $24.22
- HUN $11.15
- 52 Week High
- PTGX $60.60
- HUN $25.78
- Technical
- Relative Strength Index (RSI)
- PTGX 43.08
- HUN 38.03
- Support Level
- PTGX $41.29
- HUN $11.15
- Resistance Level
- PTGX $46.12
- HUN $12.22
- Average True Range (ATR)
- PTGX 1.83
- HUN 0.49
- MACD
- PTGX -0.19
- HUN -0.02
- Stochastic Oscillator
- PTGX 27.81
- HUN 32.19
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.